(14) It is hypothesized that GHK-Cu may influence various biochemical pathways and molecular markers related to inflammation and oxidative stress, although the specific mechanisms remain somewhat uncertain
Some of these issues could be alleviated with robust human-based research, followed by FDA approval if warranted
Injectable research protocols frequently administer GHK-Cu at a consistent daily time, while topical protocols apply at consistent intervals (often morning and/or evening) to the research area
These peptides often interact with multiple pathways involved in wound healing, angiogenesis, and tissue regeneration, making them attractive candidates for regenerative medicine applications
Split dosing, where the daily amount is divided into two administrations approximately 12 hours apart, helps maintain more consistent tissue levels throughout the day